218 related articles for article (PubMed ID: 19735093)
21. LRRK2 I2020T mutation is associated with tau pathology.
Ujiie S; Hatano T; Kubo S; Imai S; Sato S; Uchihara T; Yagishita S; Hasegawa K; Kowa H; Sakai F; Hattori N
Parkinsonism Relat Disord; 2012 Aug; 18(7):819-23. PubMed ID: 22525366
[TBL] [Abstract][Full Text] [Related]
22. Leucine-rich repeat kinase 2 is associated with the endoplasmic reticulum in dopaminergic neurons and accumulates in the core of Lewy bodies in Parkinson disease.
Vitte J; Traver S; Maués De Paula A; Lesage S; Rovelli G; Corti O; Duyckaerts C; Brice A
J Neuropathol Exp Neurol; 2010 Sep; 69(9):959-72. PubMed ID: 20720502
[TBL] [Abstract][Full Text] [Related]
23. Pathogenicity of the Lrrk2 R1514Q substitution in Parkinson's disease.
Toft M; Mata IF; Ross OA; Kachergus J; Hulihan MM; Haugarvoll K; Stone JT; Blazquez M; Gibson JM; Aasly JO; White LR; Lynch T; Adler CH; Gwinn-Hardy K; Farrer MJ
Mov Disord; 2007 Feb; 22(3):389-92. PubMed ID: 17216639
[TBL] [Abstract][Full Text] [Related]
24. Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data.
Khan NL; Jain S; Lynch JM; Pavese N; Abou-Sleiman P; Holton JL; Healy DG; Gilks WP; Sweeney MG; Ganguly M; Gibbons V; Gandhi S; Vaughan J; Eunson LH; Katzenschlager R; Gayton J; Lennox G; Revesz T; Nicholl D; Bhatia KP; Quinn N; Brooks D; Lees AJ; Davis MB; Piccini P; Singleton AB; Wood NW
Brain; 2005 Dec; 128(Pt 12):2786-96. PubMed ID: 16272164
[TBL] [Abstract][Full Text] [Related]
25. LRRK2 G2019S and R1441G mutations associated with Parkinson's disease are common in the Basque Country, but relative prevalence is determined by ethnicity.
Gorostidi A; Ruiz-Martínez J; Lopez de Munain A; Alzualde A; Martí Massó JF
Neurogenetics; 2009 Apr; 10(2):157-9. PubMed ID: 19020907
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and clinical features of LRRK2 mutations in patients with Parkinson's disease in southern Spain.
Gao L; Gómez-Garre P; Díaz-Corrales FJ; Carrillo F; Carballo M; Palomino A; Díaz-Martín J; Mejías R; Vime PJ; López-Barneo J; Mir P
Eur J Neurol; 2009 Aug; 16(8):957-60. PubMed ID: 19473361
[TBL] [Abstract][Full Text] [Related]
27. Lrrk2 mutations in South America: A study of Chilean Parkinson's disease.
Perez-Pastene C; Cobb SA; Díaz-Grez F; Hulihan MM; Miranda M; Venegas P; Godoy OT; Kachergus JM; Ross OA; Layson L; Farrer MJ; Segura-Aguilar J
Neurosci Lett; 2007 Jul; 422(3):193-7. PubMed ID: 17614198
[TBL] [Abstract][Full Text] [Related]
28. Alzheimer's disease tau is a prominent pathology in LRRK2 Parkinson's disease.
Henderson MX; Sengupta M; Trojanowski JQ; Lee VMY
Acta Neuropathol Commun; 2019 Nov; 7(1):183. PubMed ID: 31733655
[TBL] [Abstract][Full Text] [Related]
29. The familial Parkinsonism gene LRRK2 regulates neurite process morphology.
MacLeod D; Dowman J; Hammond R; Leete T; Inoue K; Abeliovich A
Neuron; 2006 Nov; 52(4):587-93. PubMed ID: 17114044
[TBL] [Abstract][Full Text] [Related]
30. Lrrk2-associated parkinsonism is a major cause of disease in Northern Spain.
González-Fernández MC; Lezcano E; Ross OA; Gómez-Esteban JC; Gómez-Busto F; Velasco F; Alvarez-Alvarez M; Rodríguez-Martínez MB; Ciordia R; Zarranz JJ; Farrer MJ; Mata IF; de Pancorbo MM
Parkinsonism Relat Disord; 2007 Dec; 13(8):509-15. PubMed ID: 17540608
[TBL] [Abstract][Full Text] [Related]
31. Interaction of LRRK2 and α-Synuclein in Parkinson's Disease.
Daher JP
Adv Neurobiol; 2017; 14():209-226. PubMed ID: 28353286
[TBL] [Abstract][Full Text] [Related]
32. Genetic screening for two LRRK2 mutations in French patients with idiopathic Parkinson's disease.
Funalot B; Nichols WC; Pérez-Tur J; Mercier G; Lucotte G
Genet Test; 2006; 10(4):290-3. PubMed ID: 17253937
[TBL] [Abstract][Full Text] [Related]
33. A novel LRRK2 mutation in an Austrian cohort of patients with Parkinson's disease.
Haubenberger D; Bonelli S; Hotzy C; Leitner P; Lichtner P; Samal D; Katzenschlager R; Djamshidian A; Brücke T; Steffelbauer M; Bancher C; Grossmann J; Ransmayr G; Strom TM; Meitinger T; Gasser T; Auff E; Zimprich A
Mov Disord; 2007 Aug; 22(11):1640-3. PubMed ID: 17523199
[TBL] [Abstract][Full Text] [Related]
34. Identification of a Japanese family with LRRK2 p.R1441G-related Parkinson's disease.
Hatano T; Funayama M; Kubo SI; Mata IF; Oji Y; Mori A; Zabetian CP; Waldherr SM; Yoshino H; Oyama G; Shimo Y; Fujimoto KI; Oshima H; Kunii Y; Yabe H; Mizuno Y; Hattori N
Neurobiol Aging; 2014 Nov; 35(11):2656.e17-2656.e23. PubMed ID: 24973808
[TBL] [Abstract][Full Text] [Related]
35. Leucine-rich repeat kinase 2 gene-associated disease: redefining genotype-phenotype correlation.
Wider C; Dickson DW; Wszolek ZK
Neurodegener Dis; 2010; 7(1-3):175-9. PubMed ID: 20197701
[TBL] [Abstract][Full Text] [Related]
36. LRRK 2 gene mutations in the pathophysiology of the ROCO domain and therapeutic targets for Parkinson's disease: a review.
Chen ML; Wu RM
J Biomed Sci; 2018 Jun; 25(1):52. PubMed ID: 29903014
[TBL] [Abstract][Full Text] [Related]
37. Isolated nigral degeneration without pathological protein aggregation in autopsied brains with LRRK2 p.R1441H homozygous and heterozygous mutations.
Takanashi M; Funayama M; Matsuura E; Yoshino H; Li Y; Tsuyama S; Takashima H; Nishioka K; Hattori N
Acta Neuropathol Commun; 2018 Oct; 6(1):105. PubMed ID: 30333048
[TBL] [Abstract][Full Text] [Related]
38. α-Synuclein, leucine-rich repeat kinase-2, and manganese in the pathogenesis of Parkinson disease.
Covy JP; Giasson BI
Neurotoxicology; 2011 Oct; 32(5):622-9. PubMed ID: 21238487
[TBL] [Abstract][Full Text] [Related]
39. LRRK2 levels and phosphorylation in Parkinson's disease brain and cases with restricted Lewy bodies.
Dzamko N; Gysbers AM; Bandopadhyay R; Bolliger MF; Uchino A; Zhao Y; Takao M; Wauters S; van de Berg WD; Takahashi-Fujigasaki J; Nichols RJ; Holton JL; Murayama S; Halliday GM
Mov Disord; 2017 Mar; 32(3):423-432. PubMed ID: 27911006
[TBL] [Abstract][Full Text] [Related]
40. The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease.
Cookson MR
Nat Rev Neurosci; 2010 Dec; 11(12):791-7. PubMed ID: 21088684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
